Format

Send to

Choose Destination
Am J Ophthalmol. 2000 Mar;129(3):372-5.

Epstein-Barr virus dacryoadenitis.

Author information

1
Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA.

Abstract

PURPOSE:

To describe the clinical features of lacrimal gland inflammation associated with Epstein-Barr virus infection.

METHODS:

The clinical records, laboratory data, and radiographs of patients who had inflammation of one or both lacrimal glands that had begun less than 4 weeks previously were reviewed.

RESULTS:

Sixteen patients with dacryoadenitis were encountered between 1980 and 1996, a cumulative frequency of approximately one case per 10,000 new ophthalmic outpatients. Six individuals had serologic or other evidence of recent Epstein-Barr virus infection and were distinguished by the presence of regional lymphadenopathy, no purulent discharge, and a duration of symptoms of 6 weeks.

CONCLUSION:

Epstein-Barr virus is a probable cause of unilateral and bilateral dacryoadenitis in young adults.

PMID:
10704555
DOI:
10.1016/s0002-9394(99)00351-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center